GF
TTPH

Gabelli Funds’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Gabelli Funds’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,500
Closed -$14K – 1156
2019
Q2 		$14K Sell
1,500
-2,600
-63% -$47.8K ﹤0.01% 1151
2019
Q1 		$110K Sell
4,100
-800
-16% -$20.4K ﹤0.01% 1102
2018
Q4 		$111K Buy
4,900
+100
+2% +$3.91K ﹤0.01% 1112
2018
Q3 		$265K Sell
4,800
-1,300
-21% -$83K ﹤0.01% 1084
2018
Q2 		$436K Sell
6,100
-100
-2% -$7.06K ﹤0.01% 1019
2018
Q1 		$381K Hold
6,200
– – ﹤0.01% 1037
2017
Q4 		$781K Sell
6,200
-200
-3% -$25.6K ﹤0.01% 938
2017
Q3 		$876K Hold
6,400
– – 0.01% 924
2017
Q2 		$913K Hold
6,400
– – 0.01% 917
2017
Q1 		$1.18M Hold
6,400
– – 0.01% 886
2016
Q4 		$516K Hold
6,400
– – ﹤0.01% 1007
2016
Q3 		$490K Buy
6,400
+400
+7% +$32K ﹤0.01% 1018
2016
Q2 		$516K Buy
6,000
+3,050
+103% +$279K ﹤0.01% 1021
2016
Q1 		$273K Buy
2,950
+450
+18% +$44.9K ﹤0.01% 1064
2015
Q4 		$502K Hold
2,500
– – ﹤0.01% 999
2015
Q3 		$373K Sell
2,500
-4,800
-66% -$3.52M ﹤0.01% 973
2015
Q2 		$6.93M Sell
7,300
-5,950
-45% -$4.86M 0.04% 505
2015
Q1 		$9.71M Buy
13,250
+10,100
+321% +$7.59M 0.05% 440
2014
Q4 		$2.5M Sell
3,150
-700
-18% -$377K 0.01% 746
2014
Q3 		$1.54M Buy
3,850
+1,850
+93% +$495K 0.01% 818
2014
Q2 		$540K Buy
+2,000
New +$429K ﹤0.01% 959

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Gabelli Funds's TTPH Position: Q3 2019 in Review

Gabelli Funds sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2019, closing a stake of 1,500 shares — an estimated $14K sold.

Gabelli Funds first reported a position in TTPH in Q2 2014 and held it in 21 quarters. The position peaked at $9.71M in Q1 2015. 26 funds tracked by Wall St. Rank hold TTPH as of Q3 2019.

  • Gabelli Funds reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Gabelli Funds sold 1,500 Tetraphase Pharmaceuticals, Inc. shares in Q3 2019, an estimated $14K.
  • Gabelli Funds first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2014 and held it in 21 quarters.
  • Gabelli Funds's Tetraphase Pharmaceuticals, Inc. position peaked at $9.71M in Q1 2015.
  • 26 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2019.

Based on Gabelli Funds's 13F filing for Q3 2019, filed 1 Nov 2019.